Visual Acuity as an Outcome Measure in Clinical Trials of Retinal Diseases

Ophthalmology

Volumn 114, Issue 10, 2007, Pages 1804-1809

  Beck, Roy W ^a   Maguire, Maureen G ^b   Bressler, Neil M ^c   Glassman, Adam R ^a   Lindblad, Anne S ^d   Ferris, Frederick L ^e  

^a JAEB CENTER FOR HEALTH RESEARCH   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d EMMES CORPORATION   (United States)

^e NATIONAL EYE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL RESEARCH; CLINICAL TRIAL; EYE EXAMINATION; HUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETINA DISEASE; SCORING SYSTEM; VISUAL ACUITY;

CLINICAL TRIALS; HUMANS; RETINAL DISEASES; TREATMENT OUTCOME; VISION TESTS; VISUAL ACUITY;

EID: 34748872167     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2007.06.047     Document Type: Article

References (11)

1. Ferris III F.L., Kassoff A., Bresnick G.H., and Bailey I. New visual acuity charts for clinical research. Am J Ophthalmol 94 (1982) 91-96
2. Beck R.W., Moke P.S., Turpin A.H., et al. A computerized method of visual acuity testing: adaptation of the Early Treatment of Diabetic Retinopathy Study testing protocol. Am J Ophthalmol 135 (2003) 194-205
3. Blackhurst D.W., Maguire M.G., and Macular Photocoagulation Study Group. Reproducibility of refraction and visual acuity measurement under a standard protocol. Retina 9 (1989) 163-169
4. Brown D.M., Kaiser P.K., Michels M., et al. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med 355 (2006) 1432-1444
5. Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema: Early Treatment Diabetic Retinopathy Study report number 1. Arch Ophthalmol 103 (1985) 1796-1806
6. Gragoudas E.S., Adamis A.P., Cunningham Jr. E.T., et al. Pegaptanib for neovascular age-related macular degeneration. N Engl J Med 351 (2004) 2805-2816
7. Rosenfeld P.J., Brown D.M., Heier J.S., et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 355 (2006) 1419-1431
8. Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-TAP report 2. Arch Ophthalmol 199 (2001) 198-207
9. Verteporfin in Photodynamic Therapy Study Group. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization-Verteporfin in Photodynamic Therapy report 2. Am J Ophthalmol 131 (2001) 541-560
10. Argon laser photocoagulation for senile macular degeneration: results of a randomized clinical trial. Arch Ophthalmol 100 (1982) 912-918
11. Sullivan L.M., and D'Agostino R.B. Robustness of the t-test applied to data distorted from normality by floor effects. J Dent Res 71 (1992) 1938-1943